Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05592600 · ClinicalTrials.gov registry record · NA
Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation in Healthy Adults
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05592600: Completed NA study, sponsored by Drexel University.
NCT05592600 is a NA study that has completed, run by Drexel University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05592600, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Healthy adult subjects will participate in two sessions. The first session will involve measurements of brain activity using simultaneous recordings with electroencephalography (EEG) and functional Magnetic Resonance Imaging (fMRI). During brain activity measurement, participants will perform cognitive tasks assessing attention. The second will involve fMRI-based neurofeedback during simultaneous EEG-fMRI recording. Participants will receive real-time visual feedback of signals measured from specific parts of their brain and will try to control that activity.
Primary Outcome
The investigators determined the degree to which features within EEG signals can approximate fMRI (default mode network activation) while participants performed cognitive tasks and brain activity was recorded with simultaneous EEG-fMRI. Model predictions (EEG prediction of fMRI) within each participant were generated from multiple EEG features, including spectral power in different frequency bands (Theta: 4-7 Hz, Alpha: 8-12 Hz, Beta1: 13-22 Hz, Beta2: 23-29 Hz, Gamma: 30-50 Hz). The average tem
Interventions
- BEHAVIORAL Neurofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-10-06 |
| Est. Completion | 2025-02-24 |
| Phase | NA |
What the finished NCT05592600 record still lists
NCT05592600 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Neurofeedback is the first listed.
NCT05592600 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05592600 about?
NCT05592600 is a clinical study titled "Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation in Healthy Adults". Healthy adult subjects will participate in two sessions. The first session will involve measurements of brain activity using simultaneous recordings with electroencephalography (EEG) and functional Magnetic Resonance Imaging (fMRI). During brain activity measurement, participants will perform cognit...
What is the current status of trial NCT05592600?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-10-06. Estimated completion is 2025-02-24.
What interventions are being tested in trial NCT05592600?
The interventions under investigation include: Neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT05592600?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05592600's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI